INTERNATIONAL PATENT: ALBERT-LUDWIGS-UNIVERSITAT FREIBURG FILES APPLICATION FOR "SYK INHIBITORS FOR USE IN THE TREATMENT OF IMMUNE CHECKPOINT INHIBITION INDUCED ADVERSE EVENTS"

GENEVA, March 17 -- ALBERT-LUDWIGS-UNIVERSITAT FREIBURG (Friedrichstrasse 3979098 Freiburg) filed a patent application (PCT/IB2024/060230) for "SYK INHIBITORS FOR USE IN THE TREATMENT OF IMMUNE CHECKPOINT INHIBITION INDUCED ADVERSE EVENTS" on Oct 17, 2024. With publication no. WO/2025/052354, the details related to the patent application was published on Mar 13, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ZEISER, Robert (Lise Meitner Str. 1079100 Freiburg)

Abstract: The present invention is directed to an inhibitor of Spleen tyrosine kinase (Syk-inhibitor) for use in the treatment or ...